SlowBull
The Business Brief SUNDAY, 9 AUGUST 2026
← All stories
Earnings

Replimune in the spotlight: Earnings loom days after FDA approval

1 source ·3 articles ·3h ago Replimune

Covered by 1 outlet

Investing 3

All coverage · 3 articles

Investing.com Canada ·3h ago

Replimune in the spotlight: Earnings loom days after FDA approval

Investing.com UK ·3h ago

Replimune in the spotlight: Earnings loom days after FDA approval

Investing.com News ·3h ago

Replimune in the spotlight: Earnings loom days after FDA approval